Artificial Intelligence is reshaping healthcare across diagnostics, treatment, and operations, and startup activity is following a clear pattern tied to technical sophistication. An analysis of 3,807 Artificial Intelligence health startups founded between 2010 and 2024 applies a five-tier Artificial Intelligence systems complexity framework to classify ventures by medical domain, Artificial Intelligence systems level, funding, geography, and team composition. The findings indicate that startup innovation and capital formation are not spread evenly across healthcare, but instead concentrate in segments where higher-complexity systems can be built and scaled more readily.
Nearly two-thirds of Artificial Intelligence investments focus on clinical decision support, drug discovery, and diagnostics, domains associated with higher-complexity deep-learning systems. Mental health, public health, and rehabilitation attract less Artificial Intelligence venture capital, reflecting scalability and data limitations rather than a lack of need. The framework suggests that system complexity helps explain why some healthcare categories draw more investor attention: applications with strong data availability, clearer technical pathways, and easier commercialization appear better positioned to attract startup formation and funding.
The study also finds that healthcare Artificial Intelligence startups remain concentrated in high-income countries. That geographic pattern points to the importance of access to capital, infrastructure, data ecosystems, and commercialization networks in determining where innovation takes hold. By comparison, lower-resource settings appear less represented in the startup landscape, raising questions about whether the benefits of healthcare Artificial Intelligence innovation will be distributed equitably across regions and care environments.
Founding teams are described as predominantly technical and business-oriented, with limited clinical representation and gender diversity. That imbalance matters because healthcare innovation often depends on aligning technical ambition with clinical workflows, patient needs, and implementation realities. The results connect team composition to broader innovation pathways, suggesting that who builds healthcare Artificial Intelligence companies can influence which problems get prioritized and how solutions are designed for adoption.
The study positions the five-tier framework as a practical lens for understanding how Artificial Intelligence system complexity shapes startup behavior, investment allocation, and innovation trajectories in digital medicine. A sample of data used in this work is available in a public GitHub repository at https://github.com/MrGluten/LLM-category-complexity. The custom code used for automated classification of healthcare startups in this study is publicly available at https://github.com/MrGluten/LLM-category-complexity under an MIT License with no restrictions on access.
